-

Philip Morris International Joins Ferrari Hypersail as Principal Partner, Building on 50-Year Relationship

As Principal Partner, PMI will help bring to life one of Ferrari’s most ambitious projects—a symbol of pioneering innovation, technology and exploration.

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (NYSE: PM) today announced it will serve as Principal Partner of Ferrari Hypersail, an initiative that applies Ferrari engineering and racing spirit to a new frontier at sea. PMI has shared with Ferrari one of the most enduring partnerships in Formula 1 since its origins in 1973 - a relationship defined by reinvention, ambition, and an unwavering belief that progress matters. Philip Morris International’s commitment to science-backed innovation, including smoke-free technologies, echoes the same passion for progress that propels Ferrari Hypersail.

Hypersail serves as a platform for breakthrough ideas that can inspire new solutions across industries, including automotive engineering, energy efficiency, and advanced control systems. The Ferrari Hypersail program centers on a 30-meter (100-foot) full-foiling ocean racing monohull that is engineered to explore new frontiers of innovation, self-sufficiency and performance in ocean racing, with launch and initial sea trials scheduled for 2026. The program will be powered entirely by renewable energy, engineered through open innovation, and shaped in collaboration with leading experts in aerodynamics, naval architecture, and high-performance systems.

Ferrari’s pursuit of record-breaking performance at sea mirrors PMI’s own journey of change and innovation - bold, forward-looking, and driven by the conviction that technology, coupled with human ingenuity, can help tackle long-standing challenges,” said Jacek Olczak, Group CEO, PMI. “This moment is more than an announcement. It is a continuation of a journey that began more than 50 years ago, charting a new course defined by shared ambition, bold challenges, and a belief that progress matters.”

I believe that true innovation is born at the intersection of diverse ideas and expertise. Our collaboration with partners is rooted in this philosophy,” Benedetto Vigna, Ferrari CEO, commented. “With Hypersail, a platform for testing and validation under extreme conditions, we are embracing a scientific approach to redefine the limits of what’s possible. This project exemplifies our shared commitment with partners to pioneering technology and innovation, and we are proud to embark on this new journey with Philip Morris International.”

Innovation and change are core to Philip Morris International’s DNA. For the first time externally, a new expression of the company’s visual identity will appear on the Ferrari Hypersail—a modern, dynamic iconography that reflects PMI’s evolution as a consumer packaged goods company.

Philip Morris International: A Global Smoke-Free Champion

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smokefree products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in 106 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41.5% of PMI’s total adjusted net revenues in 2025. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise smoke, with the goal of completely ending the sale of cigarettes. This includes the building of worldclass scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com

Contacts

Philip Morris International
Corey Henry
T. +1 (202) 679 7296
E. corey.henry@pmi.com

Philip Morris International

NYSE:PM

Release Versions

Contacts

Philip Morris International
Corey Henry
T. +1 (202) 679 7296
E. corey.henry@pmi.com

More News From Philip Morris International

Philip Morris International Presents its Value Report 2025: change in motion

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (NYSE: PM) today released its Value Report 2025, offering a holistic perspective on the company’s approach to sustainable value creation. The report marks the completion of PMI’s 2025 Roadmap, communicating achievements for each aspiration introduced by the company in 2020, and introduces its Value Plan 2030+, set to guide the company’s continued path to sustainable growth. “For more than a decade, PMI has pursued an industry-leading sh...

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

STAMFORD, CT--(BUSINESS WIRE)--Experts from Philip Morris International (PMI) (NYSE: PM) yesterday presented scientific evidence to the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA’s process for a Modified Risk Tobacco Product (MRTP) designation for their ZYN nicotine pouch products. This designation would allow PMI’s U.S. family of businesses to communicate to U.S. legal-aged, 21+ adult cigarette smokers that switching comp...

Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today released a new white paper, “Human Cognition: The Next Frontier?”, inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the “superskill” of the futu...
Back to Newsroom